Miniatura

Fitxers

jaa-15-363.pdf (1.21 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-03-01

Llicència de publicació

cc by-nc Pérez de Llano, Luis et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184730

The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.2147/JAA.S338467

Resum

Although biologics have demonstrated to be effective in T2-high asthma patients, there is little experience with these drugs in asthma-COPD overlap (ACO). The aim of this study was to compare the effectiveness of biologics in these two conditions. We included 318 patients (24 ACO and 297 asthma) treated with monoclonal antibodies and followed for at least 12 months Omalizumab was the most frequently employed biologic agent both in patients with ACO and asthma. Asthma control test (ACT) scores after at least 12 months of biologic therapy were not significantly different between groups. The percentage of patients with >= 1 exacerbation and >= 1 corticosteroid burst was significantly higher in ACO patients (70.8 vs 27.3 and 83.3% vs 37.5%, respectively), whereas the percentage of controlled patients (with no exacerbations, no need for corticosteroids and ACT >= 20) was significantly lower (16.7% vs 39.7%). In conclusion, this report suggests that patients with ACO treated with biologics reach worse outcomes than asthma patients.

Matèries

Asma, Malalties pulmonars obstructives cròniques, Utilització de medicaments

Matèries (anglès)

Asthma, Chronic obstructive pulmonary diseases, Drug utilization

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

PÉREZ DE LLANO, Luis a., DACAL RIVAS, David, MARINA MALANDA, Nuria, PLAZA MORAL, Vicente, GULLÓN BLANCO, José antonio, MUÑOZ ESQUERRE, Mariana, GARCÍA MOGUEL, Ismael, DÍAZ CAMPOS, Rocío m., MARTÍNEZ MORAGÓN, Eva, HARBENAU MENA, Alicia, COSÍO, Borja g., PADILLA GALO, Alicia, CISNEROS SERRANO, Carolina. The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome. _Journal of Asthma and Allergy_. 2022. Vol. 15, núm. 363-369. [consulta: 23 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/184730]

Exportar metadades

JSON - METS

Compartir registre